This marks the first time that a hyaluronic acid dermal filler has received FDA approval for temple hollowing. Allergan Aesthetics, an AbbVie company, announced that the FDA has approved Juvéderm ...
The Food and Drug Administration has approved the hyaluronic acid dermal filler Juvéderm Voluma XC for injection in the temple region to improve moderate to severe temple hallowing in individuals over ...
“Trout pout” is a term used to describe a common effect of too much dermal filler: when, because of overzealous injections, one’s lips are so inflated they begin to curl outwards. The other frequently ...
The US Food and Drug Administration (FDA) has approved Juvéderm Voluma XC (Allergan) to correct age-related volume deficits in the midface in adults aged 21 years and older, the company announced ...
IRVINE, Calif. - Allergan (NYSE:AGN) Aesthetics, an AbbVie company (NYSE: NYSE:ABBV), has received U.S. FDA approval for its JUVÉDERM® VOLUMA® XC product to be used in the temple region to treat ...
While we're fully aware aging skin and facial features are a part of life (and totally OK), we're also firm believers in knowing about all the options available to you. Good nutrition, great skin-care ...
Q. What are the differences between Sculptra and Voluma? Which one do you recommend? A. Sculpture and Voluma are both cosmetic treatments used for facial enhancement, but they differ significantly.
I’m embarrassed to admit how many times I’ve been offered free Botox, free Kybella, free breast augmentation, free you name it, it’s free. If I actually took everyone up on their kind offers, I would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results